A recent Food and Drug Administration inspection prompted the recall of dietary supplements distributed by Multi-Mex Distributor, the company announced Monday. According to an FDA post, the supplements in question bore a close resemblance to antibiotics available in Mexico and may have been confusing to Hispanic consumers.

The seventh annual Armada Specialty Pharmacy Summit, convened at The Wynn resort and casino this week, attracted nearly 1,500 attendees — a rise of almost 50% over 2010 — and about 80 exhibiting companies.

Missouri’s House of Representatives on Monday voted 100 in favor and 50 opposed to reclassifying pseudoephedrine as a prescription-only remedy and subsequently moved the matter to the state Senate.

Nordic Naturals is attempting to crack the mass channel code with an initial 200-store test with Walgreens, the company told Drug Store News. Nordic boasts a strong heritage across the specialty channel.

Consumers with celiac disease and gluten sensitivity now can add a popular cereal brand to their diet.

Second-quarter consolidated sales for regional supermarket chain Stater Bros. were up more than 3%, the company said.

Building on the successful introduction of the nutrition iQ program to stores, two Supervalu banners announced that they will implement an education initiative designed to help grocery shoppers navigate the aisles with great-tasting foods that meet their nutritional needs.

Patients with moderate to severe rheumatoid arthritis who respond to 12 weeks of treatment with a drug made by UCB are more likely to show improvement in their condition in the long run, according to results of a study published in the Journal of Rheumatology.

Yankee Candle is introducing a patriotic fragrance collection, the company announced.

Alkermes will buy Irish drug maker Elan’s drug formulation and manufacturing business for $960 million, the two companies said Monday.

The Food and Drug Administration will expedite its review of an investigational drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the gastrointestinal tract, the company said Tuesday.